| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $672.5M | -31.7% |
| Cost of Revenue | $38.8M | -32.9% |
| Gross Profit | $289.8M | -21.5% |
| R&D Expense | $47.2M | -15.0% |
| SG&A Expense | $117.7M | -22.8% |
| Operating Income | -$40.6M | -24.0% |
| Pre-tax Income | -$124.9M | -127.4% |
| Income Tax | -$2.5M | -101.9% |
| Net Income | -$122.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.1M | -62.5% |
| Accounts Receivable | $55.0M | -33.8% |
| Current Assets | $196.5M | -52.5% |
| Total Assets | $802.8M | -33.1% |
| Current Liabilities | $75.6M | -8.4% |
| Long-term Debt | $525.6M | -35.4% |
| Total Liabilities | $678.6M | -31.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Investing Cash Flow | -$12.5M | +55.2% |
| Financing Cash Flow | -$242.0M | -843.8% |
| +34.9% |
| EPS (Basic) | -$9.46 | +35.6% |
| EPS (Diluted) | -$9.46 | +35.6% |
| Stockholders' Equity |
| $124.1M |
| -40.3% |